Capricor Therapeutics - 17 Year Stock Price History | CAPR

Historical daily share price chart and data for Capricor Therapeutics since 2007 adjusted for splits and dividends. The latest closing stock price for Capricor Therapeutics as of April 26, 2024 is 5.41.
  • The all-time high Capricor Therapeutics stock closing price was 13150.00 on March 27, 2007.
  • The Capricor Therapeutics 52-week high stock price is 8.22, which is 51.9% above the current share price.
  • The Capricor Therapeutics 52-week low stock price is 2.68, which is 50.5% below the current share price.
  • The average Capricor Therapeutics stock price for the last 52 weeks is 4.67.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Capricor Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 5.1094 5.1200 7.0950 3.6100 5.4100 10.63%
2023 4.3936 3.8500 7.8500 2.7100 4.8900 26.68%
2022 4.3533 3.1800 6.5500 2.8300 3.8600 31.74%
2021 4.4994 3.7400 7.9300 2.8900 2.9300 -14.58%
2020 3.9987 1.2300 9.8100 0.9400 3.4300 167.97%
2019 3.6947 4.9500 6.7990 1.0400 1.2800 -68.78%
2018 12.6679 15.7000 20.9000 3.2000 4.1000 -74.05%
2017 19.8844 25.5000 34.5000 6.3400 15.8000 -40.60%
2016 31.8688 29.4000 47.5000 20.1000 26.6000 -13.46%
2015 52.2587 37.5000 102.5000 26.5000 30.7360 -18.04%
2014 59.7329 34.0000 155.0000 34.0000 37.5000 15.38%
2013 37.0119 20.0000 95.0000 15.0000 32.5000 30.00%
2012 118.4200 275.0000 290.0000 15.0000 25.0000 -90.91%
2011 317.1230 290.0000 440.0000 240.0000 275.0000 -11.29%
2010 354.5833 605.0000 630.0000 150.0000 310.0000 -48.76%
2009 567.4603 400.0000 1080.0000 165.0000 605.0000 42.35%
2008 2023.9130 2750.0000 2750.0000 210.0000 425.0000 -84.55%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.162B $0.025B
Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $185.422B 24.34
Stryker (SYK) United States $128.275B 31.81
Boston Scientific (BSX) United States $107.479B 34.23
Medtronic (MDT) Ireland $105.230B 14.90
EssilorLuxottica (ESLOY) France $98.467B 0.00
Lonza Group Ag (LZAGY) Switzerland $42.075B 0.00
Haleon (HLN) United Kingdom $38.356B 30.00
ResMed (RMD) United States $26.979B 25.30
Terumo (TRUMY) Japan $24.775B 34.99
Zimmer Biomet Holdings (ZBH) United States $24.604B 15.84
Baxter (BAX) United States $20.430B 14.90
Koninklijke Philips (PHG) Netherlands $19.242B 15.35
Insulet (PODD) United States $11.496B 60.36
Smith & Nephew SNATS (SNN) United Kingdom $10.440B 0.00
Demant (WILYY) Denmark $9.943B 0.00
Bio-Rad Laboratories (BIO) United States $7.860B 23.42
BellRing Brands (BRBR) United States $7.238B 38.92
Lantheus Holdings (LNTH) United States $4.470B 11.54
Haemonetics (HAE) United States $4.452B 22.77
Perrigo (PRGO) Ireland $4.238B 12.12
GN Store Nord (GNNDY) Denmark $3.889B 25.18
Prestige Consumer Healthcare (PBH) United States $3.482B 16.47
Envista Holdings (NVST) United States $3.441B 13.09
QuidelOrtho (QDEL) United States $2.654B 9.63
Neogen (NEOG) United States $2.591B 24.92
Green Thumb Industries (GTBIF) United States $2.482B 78.67
ICU Medical (ICUI) United States $2.303B 17.19
TG Therapeutics (TGTX) United States $2.150B 695.50
Maravai LifeSciences Holdings (MRVI) United States $1.906B 0.00
Owens & Minor (OMI) United States $1.848B 17.74
Agios Pharmaceuticals (AGIO) United States $1.780B 0.00
Verano Holdings (VRNOF) United States $1.617B 0.00
InMode (INMD) Israel $1.429B 7.40
LeMaitre Vascular (LMAT) United States $1.414B 46.66
National Vision Holdings (EYE) United States $1.399B 43.58
AdaptHealth (AHCO) United States $1.273B 9.58
Warby Parker (WRBY) United States $1.254B 0.00
AtriCure (ATRC) United States $1.094B 0.00
MacroGenics (MGNX) United States $0.899B 0.00
Canopy Growth (CGC) Canada $0.872B 0.00
BioLife Solutions (BLFS) United States $0.764B 0.00
VAREX IMAGING (VREX) United States $0.686B 14.82
Cresco Labs (CRLBF) United States $0.674B 0.00
Evolus (EOLS) United States $0.664B 0.00
Jin Medical (ZJYL) China $0.608B 0.00
Quanterix (QTRX) United States $0.596B 0.00
Valneva SE (VALN) France $0.526B 0.00
Phibro Animal Health (PAHC) United States $0.504B 10.91
PetIQ (PETQ) United States $0.480B 17.93
TerrAscend (TSNDF) Canada $0.462B 0.00
ZimVie (ZIMV) United States $0.421B 25.80
Biote (BTMD) United States $0.416B 3.96
OraSure Technologies (OSUR) United States $0.402B 6.66
Surmodics (SRDX) United States $0.373B 40.26
Aurora Cannabis (ACB) Canada $0.366B 0.00
Zynex (ZYXI) United States $0.352B 40.52
Viemed Healthcare (VMD) United States $0.310B 30.81
Cerus (CERS) United States $0.308B 0.00
Sanara MedTech (SMTI) United States $0.278B 0.00
TriSalus Life Sciences (TLSI) United States $0.266B 0.00
Utah Medical Products (UTMD) United States $0.238B 14.73
Organigram Holdings (OGI) Canada $0.192B 0.00
Ayr Wellness (AYRWF) United States $0.178B 0.00
Omeros (OMER) United States $0.177B 0.00
Veru (VERU) United States $0.177B 0.00
High Tide (HITI) Canada $0.161B 0.00
Quipt Home Medical (QIPT) United States $0.156B 0.00
Eagleford Energy (GRUSF) United States $0.141B 70.99
FitLife Brands (FTLF) United States $0.129B 20.74
Jushi Holdings (JUSHF) United States $0.125B 0.00
InterCure (INCR) Israel $0.120B 20.31
Fonar (FONR) United States $0.107B 9.16
MariMed (MRMD) United States $0.100B 0.00
Cellectar Biosciences (CLRB) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
Allurion Technologies (ALUR) United States $0.089B 0.00
Safety Shot (SHOT) United States $0.082B 0.00
Brainsway (BWAY) Israel $0.080B 0.00
Chimerix (CMRX) United States $0.079B 0.00
Zevia PBC (ZVIA) United States $0.059B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.055B 3.59
Apyx Medical (APYX) United States $0.051B 0.00
Rockwell Medical (RMTI) United States $0.044B 0.00
Cytosorbents (CTSO) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
United-Guardian (UG) United States $0.038B 14.95
Bright Green (BGXX) United States $0.035B 0.00
Modular Medical (MODD) United States $0.033B 0.00
Exagen (XGN) United States $0.024B 0.00
Nephros (NEPH) United States $0.023B 0.00
Flora Growth (FLGC) United States $0.020B 0.00
FSD PHARMA (HUGE) Canada $0.019B 0.00
Agape ATP (ATPC) $0.019B 0.00
Meihua Medical Technologies (MHUA) China $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
GlucoTrack (GCTK) United States $0.012B 0.00
GUARDION HEALTH (GHSI) United States $0.010B 74.09
NeuroMetrix (NURO) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.008B 0.00
Leafly Holdings (LFLY) United States $0.004B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
Innovative Eyewear (LUCY) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.002B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
Bruush Oral Care (BRSH) $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00